4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-038978
Director sold 94,378 shares at an average $70.35 ($6,639,523)
- Director acquired 94,378 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tessier-Lavigne Marc · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-07 | Exercise or conversion : show line 1 in the form | +39,303 | $18.00 | $707,454 | 2,583,673 | D |
| 2021-06-07 | Exercise or conversion : show line 2 in the form | +27,830 | $18.92 | $526,544 | 2,611,503 | D |
| 2021-06-07 | Exercise or conversion : show line 3 in the form | +27,245 | $19.50 | $531,278 | 2,638,748 | D |
| 2021-06-07 | Sale : show line 4 in the form | −93,678 | $70.35 | $6,589,779 | 2,545,070 | D |
| 2021-06-07 | Sale : show line 5 in the form | −700 | $71.06 | $49,744 | 2,544,370 | D |
| Open-market sales · 94,378 sh · avg $70.35 · $6,639,523 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-07 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −39,303 | 7,862 | D |
| 2021-06-07 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −27,830 | 0 | D |
| 2021-06-07 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −27,245 | 0 | D |
Loading xslF345X03/doc4.xml…